ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Daily Levitra Improves Inflammation and Testosterone in Men with Diabetes
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 18651" data-attributes="member: 3"><p>Chronic treatment with the phosphodiesterase-5 (PDE-5) inhibitor vardenafil (<em>Levitra</em>, Bayer/GlaxoSmithKline) for 6 months in men with type 2 diabetes is safe, improves both endothelial function and measures of hemodynamic function, and reduces inflammatory markers.</p><p>And a novel and unexpected finding of the treatment for erectile dysfunction was an improvement in testosterone serum levels in a subset of hypogonadal diabetic men.</p><p>"Importantly, the clinical trial was originated by investigators, not a drug company," Dr Daniele Santi (University of Modena, Italy), lead investigator, told <em>Medscape Medical News</em>. Dr Santi received the European Society of Endocrinology Young Investigator Award for his study, presented here at the <a href="http://www.medscape.com/viewcollection/33393" target="_blank">European Congress of Endocrinology (ECE) 2015</a>.</p><p></p><p><a href="http://www.medscape.com/viewarticle/845054" target="_blank">http://www.medscape.com/viewarticle/845054</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 18651, member: 3"] Chronic treatment with the phosphodiesterase-5 (PDE-5) inhibitor vardenafil ([I]Levitra[/I], Bayer/GlaxoSmithKline) for 6 months in men with type 2 diabetes is safe, improves both endothelial function and measures of hemodynamic function, and reduces inflammatory markers. And a novel and unexpected finding of the treatment for erectile dysfunction was an improvement in testosterone serum levels in a subset of hypogonadal diabetic men. "Importantly, the clinical trial was originated by investigators, not a drug company," Dr Daniele Santi (University of Modena, Italy), lead investigator, told [I]Medscape Medical News[/I]. Dr Santi received the European Society of Endocrinology Young Investigator Award for his study, presented here at the [URL="http://www.medscape.com/viewcollection/33393"]European Congress of Endocrinology (ECE) 2015[/URL]. [url]http://www.medscape.com/viewarticle/845054[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Daily Levitra Improves Inflammation and Testosterone in Men with Diabetes
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top